Küçük hücreli prostat karsinomu: Olgu sunumu

Abstract

Nöroendokrin hücreler prostat dokusunda bol olarak bulunur ve doğumda prostat içerisinde yaygın dağılım gösterirler. Bu olgu sunumundaki 63 yaşındaki hasta tarafımıza başvurduğunda yapılan incelemelerde 6 aydır alt üriner sistem semptomları AÜSS mevcuttu ve 2 aydır alfabloker tedavisi alıyordu. Prostat spesifik antijen PSA değeri 3 ng/ml olarak ölçüldü. AÜSS nedeniyle incelenen hastaya Ocak 2013’te TUR-P operasyonu yapıldı. Patoloji sonucu Küçük hücreli asiner karsinom olarak rapor edildi. Daha sonra hastaya tek ajan karboplatin AUC 5 kemoterapisi ve palyatif radyoterapi planlandı. Hasta tolere edemediği için birinci kürden sonra kemoterapi kesildi ve hasta tanının dördüncü ayında kaybedildi

Keywords

• Prostat,prostat kanseri,küçük hücreli kanser

Small cell prostate carsinoma: A case report

Abstract

There are plenty of neuroendocrine cells in the prostatic tissue and these are widely distributed to prostate. In this case report a 63 years old patient had lower urinary tract symptoms for 6 months. He was using alpha blocker treatment for 2 months. His prostate specific antigen PSA value was 3ng/ml. TUR-P operation was performed at January 2013. Pathology result is reported as small cell carcinoma of prostate. After diagnosis, single agent carboplatin AUC 5 chemotherapy and palliative radiotherapy were planned. Chemotherapy was stopped after first cure because of intolerance of patient. He is deceased at fourth month of diagnosis

Keywords

• Prostate,prostate cancer,small cell carcinoma

References

1. Epstein JI, Walsh P, Retik AB, Vaughan ED. Pathology of prostatic neoplasia. Campbell’s Urology. Philadelphia; El- sewier 2007. p. 2880.
2. Abbas F, Civantos F, Benedetto P, Soloway M. Small cell car- cinoma of the bladder and prostate. Urology 1995;46:617- 30.
3. Burchardt T, Burchardt M, Chen MW et al. Transdifferen- tiation of prostat cancer cells to a neoroendocrine cell phe- notype in vitro and in vivo. J Urol 1999;162:1800-5.
4. Di Sant’Agnese PA. Neuoroendocrine differentiation in human prostatic carcinoma. Hum Patol 1992. p. 287-96.
5. Wu JT, Astill ME, Liu GH, Stephenson RA. Serum chro- mogranin A: Early detection of hormonal resistance in prostate cancer patients. J Clin Lab Anal 1998;12:20-5.
6. Diaz M, Abdul M, Hoosein N. Modulation of neuroen- docrine differentiation in prostate cancer by interleukin-1 and-2. Prostate Suppl 1998;8:32-6.
7. Papandreou CN, Daliani DD, Thall PF et al. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 2002;20:3072-80.
8. Katou M, Soga N, Onishi T, Arima K, Sugimura Y. Small cell carcinoma of the prostate treated with amrubicin. Int J Clin Oncol 2008;13:169-72.

9. Oesterling JE, Hauzeur CG, Farrow GM. Small cell anap- lastic carcinoma of the prostate: a clinical, pathologi- cal and immunohistological study of 27 patients. J Urol 1992;147:804-7.
10. Sella A, Konichezky M, Flex D, Sulkes A, Baniel J. Low PSA metastatic androgen independent prostate cancer. Eur Urol 2000;38:255-8.
11. Têtu B, Ro JY, Ayala AG et al. Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Can- cer 1987;59:1803-9.
12. Shamelian SO, Nortier JW. Extrapulmonary small-cell car- cinoma: report of three cases and update of therapy and prognosis. Neth J Med 2000;56:51-5.
13. Benchekroun A, Nouini Y, Zannoud M et al. Small cell carcinoma of the prostate: a case report. Ann Urol 2002;36:314-7.
14. Anker CJ, Dechet C, Isaac JC, Akerley W, Shrieve DC. Small-cell carcinoma of the prostate. J Clin Oncol 2008;26:1168-71.
15. Asmis TR, Reaume MN, Dahrouge S, Malone S. Genitou- rinary small cell carcinoma: a retrospective review of treat- ment and survival patterns at The Ottawa Hospital Regio- nal Cancer Center. BJU Int 2006;97:711-5.
16. Uemura Kİ, Nakagawa G, Chikui K et al. A useful treat- ment for patients with advanced mixed-type small cell neuroendocrine carcinoma of the prostate: A case report. Oncol Lett 2013;5:793-6.
17. Wang J., Wang FW. Impact of age on clinical presentati- on, treatment, and cancer-specific survival of patients with small-cell carcinoma of the prostate. Clin Interv Aging 2013;8:871-7.